Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Celadon Pharmaceuticals Fundamentals (CEL)
CEL Share
Price
CEL Share
News
CEL Share
Chat
CEL Share
Trades
CEL
Live RNS
CEL Share
Charts
CEL Broker
Ratings
CEL Directors
Deals
CEL Financial
Diary
CEL
Fundamentals
CEL Short
Positions
CEL
Media
CEL Company
Research
CEL Company
Timeline
Celadon Pharmaceuticals Information
- This share is currently suspended. It was suspended at a price of 13.40
- There is currently no data for CEL
CEL Fundamentals
| Standard | IFRS | IFRS | IFRS | IFRS | IFRS |
|---|---|---|---|---|---|
| Millions | Millions | Millions | Millions | Millions | |
| Income Statement | 31 Dec '23 | 31 Dec '22 | 31 Dec '21 | 30 Aug '20 | 30 Aug '19 |
| Revenue | 0.07 | 0.02 | n/a | n/a | n/a |
| Operating Profit / Loss | (5.93) | (5.38) | (2.71) | (0.19) | (0.21) |
| Net Interest | (0.57) | (0.02) | (1.31) | 0.01 | 0.01 |
| Pre Tax Profit | (7.52) | (18.12) | (4.80) | (0.17) | (0.19) |
| Post Tax Profit | (7.26) | (17.41) | (4.78) | (0.17) | (0.19) |
| Profit for the Period | (7.26) | (17.41) | (4.78) | (0.17) | (0.19) |
| Equity Holders of Parent Company | (7.14) | (17.01) | (4.63) | (0.17) | (0.19) |
| Minority Interests | (0.12) | (0.41) | (0.16) | n/a | n/a |
| Continuing EPS | |||||
| Earnings per Share (Basic) | (11.50p) | (29.70p) | (7.87p) | (2.85p) | (3.60p) |
| Earnings per Share (Diluted) | (11.50p) | (29.70p) | (7.87p) | (2.85p) | (3.60p) |
| Earnings per Share (Adjusted) | (11.50p) | (29.70p) | (7.87p) | (2.85p) | (3.60p) |
| Continuing and Discontinued EPS | |||||
| Earnings per Share (Basic) | (11.50p) | (29.70p) | (7.87p) | (2.85p) | (3.60p) |
| Earnings per Share (Diluted) | (11.50p) | (29.70p) | (7.87p) | (2.85p) | (3.60p) |
| Earnings per Share (Adjusted) | (11.50p) | (29.70p) | (7.87p) | (2.85p) | (3.60p) |
| Dividend per Share | n/a | n/a | n/a | n/a | n/a |
| Millions | Millions | Millions | Millions | Millions | |
| Balance Sheet | 31 Dec '23 | 31 Dec '22 | 31 Dec '21 | 30 Aug '20 | 30 Aug '19 |
| Non-Current Assets | |||||
| Intangible Assets | 0.33 | 0.43 | 1.17 | n/a | n/a |
| Property, Plant and Equipment | 6.17 | 6.28 | 3.31 | n/a | n/a |
| Investments | 0.22 | 0.22 | 0.20 | n/a | n/a |
| Investment Properties | n/a | n/a | n/a | n/a | n/a |
| Other Financial Assets | n/a | n/a | n/a | n/a | n/a |
| Other Non-Current Assets | n/a | n/a | n/a | n/a | n/a |
| Total Non-Current Assets | 6.72 | 6.92 | 4.67 | n/a | n/a |
| Current Assets | |||||
| Inventories | 0.06 | 0.02 | n/a | n/a | n/a |
| Trade and Other Receivables | 1.14 | 1.25 | 0.26 | 0.01 | 0.02 |
| Cash at Bank and in Hand | 1.26 | 5.06 | 3.82 | 5.49 | 5.65 |
| Current Asset Investments | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 0.04 | n/a | n/a | n/a | n/a |
| Total Current Assets | 2.50 | 6.33 | 4.09 | 5.50 | 5.66 |
| Other Assets | n/a | n/a | n/a | n/a | n/a |
| Total Assets | 9.22 | 13.25 | 8.76 | 5.50 | 5.66 |
| Current Liabilities | |||||
| Borrowings | 0.07 | 0.07 | 7.43 | n/a | n/a |
| Other Current Liabilities | 0.88 | 1.13 | 1.15 | 0.03 | 0.02 |
| Total Current Liabilities | 0.95 | 1.20 | 8.58 | 0.03 | 0.02 |
| Net Current Assets | n/a | n/a | n/a | n/a | n/a |
| Non-Current Liabilities | |||||
| Borrowings | 4.64 | 4.57 | 4.49 | n/a | n/a |
| Provisions | 0.44 | 0.45 | 0.09 | n/a | n/a |
| Other Non-Current Liabilities | n/a | n/a | n/a | 0.01 | 0.01 |
| Total Non-Current Liabilities | 5.09 | 5.02 | 4.57 | 0.01 | 0.01 |
| Net Assets | 3.18 | 7.04 | (4.40) | 5.46 | 5.63 |
| Capital and Reserves | |||||
| Share Capital | 0.64 | 0.62 | 0.08 | 0.06 | 0.06 |
| Share Premium Account | 25.50 | 22.55 | 7.37 | 5.71 | 5.71 |
| Other Reserves | 7.74 | 7.31 | (5.79) | 0.05 | 0.05 |
| Retained Earnings | (30.73) | (22.81) | (5.80) | (0.37) | (0.19) |
| Shareholders Funds | 3.16 | 7.67 | (4.14) | 5.46 | 5.63 |
| Minority Interests / Other Equity | 0.02 | (0.64) | (0.26) | n/a | n/a |
| Total Equity | 3.18 | 7.04 | (4.40) | 5.46 | 5.63 |
| 31 Dec '23 | 31 Dec '22 | 31 Dec '21 | 30 Aug '20 | 30 Aug '19 | |
| Operating Margin | (7,908.00%) | (22,420.83%) | (135,650.00%) | n/a | n/a |
| Return on Capital Employed | n/a | n/a | n/a | n/a | n/a |
| Dividend Cover | n/a | n/a | n/a | n/a | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | n/a | n/a | n/a | n/a | n/a |
| PEG | n/a | n/a | n/a | n/a | n/a |
| Dividend per Share Growth | n/a | n/a | n/a | n/a | n/a |
| Net Asset Value per Share | 4.44p | 10.29p | (8.66p) | 8.50p | 8.77p |
Follow the stocks
